University of York, York, UK.
Int J Health Policy Manag. 2020 Jun 1;9(6):260-262. doi: 10.15171/ijhpm.2019.118.
A recent paper by Grutters et al makes the case for early health economic modeling in the development of health technologies. A number of examples of the value of early modeling are given, with analyses being performed at different stages in the development of several non-drug health technologies. This commentary acknowledges the contribution of the paper by Grutters et al and argues for an iterative and integrated approach to early modeling, assessing the cost-effectiveness of the technology, the value of future research and the interaction with the manufacturer's pricing and revenue expectations.
格鲁特斯等人最近的一篇论文提出,在开发医疗技术时应尽早进行健康经济建模。文中列举了一些早期建模价值的实例,对几种非药物医疗技术的不同开发阶段进行了分析。这篇评论承认了格鲁特斯等人的论文的贡献,并主张对早期建模采用迭代和综合的方法,评估技术的成本效益、未来研究的价值以及与制造商定价和收入预期的相互作用。